Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Shanghai Henlius CEO Wants To Capitalize On First-Mover Status
Scott Liu Sets Out Ambitions That Go Beyond China
Feb 04 2020
•
By
Dave Wallace
Shanghai Henlius CEO Dr. Scott Liu says the leading Chinese biologics player will seek to capitalize on its first-mover status • Source: Shanghai Henlius Biotech
More from Strategy
More from Business